The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis

Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

Ravinder N. Maini, Peter C. Taylor, Jacek Szechiński et al. · Arthritis & Rheumatism · 2006 · 792 citations

Medicine, Pharmacology, Pharmacotherapy +17

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Daniel E. Fürst, Edward Keystone, Jürgen Braun et al. · Annals of the Rheumatic Diseases · 2011 · 692 citations

Medicine, Internal Medicine, Pharmacotherapy +16

Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab

J. Brandt, Hildrun Haibel, Daniel Cornely et al. · Arthritis & Rheumatism · 2000 · 488 citations

Medicine, Clinical Sciences, Immunology +12

SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITY

Jordi Gratacós, A. Collado, Xavier Filella et al. · Lara D. Veeken · 1994 · 336 citations

Medicine, Immunology, Immunopathology +8

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

Hildrun Haibel · Annals of the Rheumatic Diseases · 2004 · 218 citations · Full text

Medicine, Pharmacotherapy, Radiology +17